companyprofile
Actions
Middle East Healthcare Co.
- Main Market
- Health Care Equipment & Svc
- Sukuk and Bonds
- Saudi German Health Sukuk
Stats Overview
-
Prev. Close 64.80
-
Open 64.30
-
High 65.40
-
Low 64.10
-
No. of Trades 1,667
-
Avg. Trade size* 238
-
Volume Traded 395,998
-
Value Traded (^) 25,687,756.70
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 24/03/2025 | N/A | N/A | Account Transfer | ^0.50 |
| 29/03/2018 | 24/06/2018 | 12/07/2018 | Account Transfer | ^2.00 |
| 05/03/2017 | 08/06/2017 | 21/06/2017 | Account Transfer | ^2.00 |
| 20/04/2016 | 29/06/2016 | 28/07/2016 | Account Transfer | ^2.00 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| Total Assets |
5,125,314
|
5,173,150
|
- | - |
| Total Liabilities |
3,451,253
|
3,608,388
|
- | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,626,109
|
1,519,080
|
- | - |
| Total Liabilities and Shareholders Equity |
5,125,314
|
5,173,150
|
- | - |
| Statement of Income | 2024-12-31 | 2023-12-31 | ||
| Total Revenue (Sales/Operating) |
2,882,818
|
2,653,170
|
- | - |
| Net Profit (Loss) before Zakat and Tax |
308,279
|
198,159
|
- | - |
| Zakat and Income Tax |
-26,277
|
-17,983
|
- | - |
| Net Profit (Loss) after Zakat and Tax |
282,002
|
180,176
|
- | - |
| Total Comprehensive Income |
306,499
|
154,119
|
- | - |
| Profit (Loss) per Share |
3.06
|
1.96
|
- | - |
| Cash Flows | 2024-12-31 | 2023-12-31 | ||
| Net Cash From Operating Activities |
939,264
|
191,083
|
- | - |
| Net Cash From Investing Activities |
-507,294
|
-241,989
|
- | - |
| Net Cash From Financing Activities |
-424,110
|
79,726
|
- | - |
| Cash and Cash Equivalents, Beginning of the Period |
44,423
|
15,602
|
- | - |
| Cash and Cash Equivalents, End of the Period |
52,283
|
44,423
|
- | - |
| All Figures in | Thousands | Thousands | ||
| All Currency In | ^ | ^ | ||
| Last Update Date | 2025-03-03 | 2024-04-03 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|---|
| Total Assets |
5,161,985
|
5,251,980
|
4,979,766
|
4,986,420
|
| Total Liabilities |
3,415,769
|
3,570,654
|
3,361,939
|
3,428,705
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,699,328
|
1,636,633
|
1,572,117
|
1,510,009
|
| Total Liabilities and Shareholders Equity |
5,161,985
|
5,251,980
|
4,979,766
|
4,986,420
|
| Statement of Income | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Total Revenue (Sales/Operating) |
732,074
|
712,657
|
689,210
|
671,047
|
| Net Profit (Loss) before Zakat and Tax |
72,727
|
68,435
|
59,167
|
58,028
|
| Zakat and Income Tax |
-10,983
|
-7,264
|
-7,224
|
-4,725
|
| Net Profit (Loss) after Zakat and Tax |
61,744
|
61,171
|
51,943
|
53,303
|
| Total Comprehensive Income |
62,696
|
64,515
|
53,038
|
54,125
|
| Profit (Loss) per Share |
0.67
|
0.66
|
0.56
|
0.58
|
| Cash Flows | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Net Cash From Operating Activities |
637,635
|
239,912
|
197,996
|
163,891
|
| Net Cash From Investing Activities |
-434,685
|
-115,135
|
-37,873
|
-185,141
|
| Net Cash From Financing Activities |
-197,509
|
-96,892
|
-182,873
|
70,862
|
| Cash and Cash Equivalents, Beginning of the Period |
44,423
|
44,423
|
44,423
|
15,602
|
| Cash and Cash Equivalents, End of the Period |
49,864
|
72,308
|
21,673
|
65,214
|
| All Figures in | Thousands | Thousands | Thousands | Thousands |
| All Currency In | ^ | ^ | ^ | ^ |
| Last Update Date | 2024-11-04 | 2024-08-04 | 2024-05-05 | 2023-11-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
Construct, manage, operate and maintenance for hospitals, clinics, centers, institutes, rehabilitation centers, physiotherapy, laboratory, X-Ray, pharmacies, purchasing of lands to construct buildings and investment for the company in medical projects
Company History
Middle East Healthcare Company (MEAHCO) is a closed joint stock company incorporated pursuant to the Ministerial Resolution number 2554 dated 16/03/1425H (corresponding to 05/05/2004G) and registered under commercial registration number 4030149460 dated 06/04/1425H (corresponding to 25/05/2004G) with a paid-up share capital of (SAR 590000000) five hundred and ninety million Saudi Riyals, of which (SAR 42040000) forty-two million and forty thousand Saudi Riyals were paid through cash contributions, while the remaining (SAR 547960000) five hundred and forty seven million and nine hundred and sixty thousand Saudi Riyals were paid through in kind contributions made by BAB consisting of SGH Madinah (including its land and buildings) SGH Aseer (including its land and buildings) and shares representing 80% of the share capital of BABAS (former owner and operator of SGH Riyadh) On 02/02/1435H (corresponding to 5/12/2013G) the EGA of the Company agreed to increase the Companies share capital from (SAR 590000000) five hundred ninety million Saudi Riyals to (SAR 767000000) seven hundred sixty seven million Saudi Riyals The increase of (SAR 177000000) one hundred and seventy seven million Saudi Riyals was covered through capitalization of the Shareholders account that resulted from their offering of additional in kind contributions to the Company which consisted of the following 1 SGH Jeddah 2 98% of the shares of AJ Sons 3 39.96% of NHCs share capital 4 Management Supervision Agreements for hospitals owned by third parties outside the Kingdom located in Dubai (UAE) Cairo (Egypt) and Sanaa (Yemen) 5 20% of BABAS which resulted in the Company fully owning BABAS and therefore fully owning SGH Riyadh which was later converted into a fully owned branch by the Company under commercial registration number 1010162269 dated 24/07/1421H (corresponding to 21/10/2000G) and a plot of land in the city of Dammam with a surface area of (30,000) thirty thousand m2 (Dammam Land) On 28/7/1436H (corresponding to 17/5/2015G) the EGA agreed to further increase the Companies share capital from (SAR 767000000) seven hundred and sixty-seven million Saudi Riyals to (SAR 920400000) nine hundred and twenty million four hundred thousand Saudi Riyals The increase of (SAR 153400000) one-hundred and fifty-three million four hundred thousand Saudi Riyals was covered through capitalization of the retained earnings account
Company Bylaws
Equity Profile
- Authorized Capital (^) 920,400,000
- Issued Shares 92,040,000
- Paid Capital (^) 920,400,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2016-03-28
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on the company's bylaw and the issued instructions by the related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
MUATH MOHAMMED ALZARKAN
Company Address:
Jeddah, Batterjee Street, Al Zahra District P.O.BOX2550 Jeddah 21461
Contact Details:
Telephone:
0966-12-2606000
Fax
: 00966-12-6835874
Email
: president4@sghgroup.net
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}